Altamira Therapeutics's market cap is currently $492.91K. The company's EPS TTM is $; its P/E ratio is ―; Altamira Therapeutics is scheduled to report earnings on April 9, 2025, and the estimated EPS forecast is $-0.54. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	CHF 0.00	CHF 305.62K	CHF 63.88K	CHF 174.47K	CHF -56.00K
Gross Profit	CHF 0.00	CHF -1.14M	CHF -2.18M	CHF 174.47K	CHF -56.00K
Operating Income	CHF -5.92M	CHF -26.13M	CHF -17.10M	CHF -5.28M	CHF -7.26M
EBITDA	CHF -1.35M	CHF -17.64M	CHF -6.72M	CHF -5.26M	CHF -7.24M
Net Income	CHF -7.27M	CHF -26.53M	CHF -17.39M	CHF -8.20M	CHF -6.63M
Balance Sheet
Cash & Short-Term Investments	CHF 617.41K	CHF 15.39K	CHF 984.19K	CHF 11.26M	CHF 1.38M
Total Assets	CHF 7.69M	CHF 6.30M	CHF 18.84M	CHF 20.80M	CHF 9.23M
Total Debt	CHF 99.66K	CHF 6.33M	CHF 575.74K	CHF 523.92K	CHF 0.00
Net Debt	CHF -517.75K	CHF 6.32M	CHF -408.45K	CHF -10.73M	CHF -1.38M
Total Liabilities	CHF 1.24M	CHF 14.62M	CHF 6.13M	CHF 4.03M	CHF 3.19M
Stockholders' Equity	CHF 6.46M	CHF -8.31M	CHF 12.70M	CHF 16.77M	CHF 6.04M
Cash Flow
Free Cash Flow	CHF -11.51M	CHF -10.83M	CHF -17.00M	CHF -7.16M	CHF -11.41M
Operating Cash Flow	CHF -11.51M	CHF -8.68M	CHF -13.67M	CHF -4.84M	CHF -8.39M
Investing Cash Flow	CHF 1.44M	CHF -2.14M	CHF -3.51M	CHF -2.31M	CHF -3.00M
Financing Cash Flow	CHF 10.62M	CHF 9.83M	CHF 6.61M	CHF 16.96M	CHF 7.38M

Currency in CHF

Altamira Therapeutics Earnings and Revenue History

Income Statement >

Altamira Therapeutics Debt to Assets

Balance Sheet >

Altamira Therapeutics Cash Flow

Cash Flow >

Altamira Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing